SCHEMBL1008430

SCHEMBL1008430

Cc1ccc(O)c2c1CCC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.44
MAOB P27338 3/20 0.44
BCL2L1 Q07817 1/20 0.41
BAD Q92934 1/20 0.41
AR P10275 1/20 0.41
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
TP53 P04637 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ADRB2 P07550 4/20 0.37
ADRB1 P08588 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12909320 0.95 BCL2L1 (0.46) MAOAMAOBBCL2L1BADAR
SCHEMBL10802712 0.87 BCL2L1 (0.50) MAOAMAOBBCL2L1BADAR
SCHEMBL31598395 0.84 DRD4 (0.42) MAOAMAOBTP53KDM4EHPGD
SCHEMBL5029748 0.84 DRD4 (0.42) MAOAMAOBTP53KDM4EHPGD
SCHEMBL3283307 0.81 BCL2L1 (0.56) MAOAMAOBBCL2L1BADAR
SCHEMBL29851805 0.78 RXRA (0.39) MAOAMAOBBCL2L1BADTP53
SCHEMBL19322587 0.78 RXRA (0.39) MAOAMAOBBCL2L1BADTP53
SCHEMBL22271609 0.76 MAOA (0.43) MAOAMAOBTP53TDP1KDM4E
SCHEMBL16518067 0.74 PNMT (0.40) MAOAMAOBKDM4EADRA2A
SCHEMBL14481407 0.74 CYP1A2 (0.38) MAOAMAOBTP53KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239761-A1 BICYCLIC PHENOL COMPOUNDS AND USE THEREOF MEDSHINE DISCOVERY INC. (CN) 2024-07-18 US disclosed
US-20240239761-A1 BICYCLIC PHENOL COMPOUNDS AND USE THEREOF MEDSHINE DISCOVERY INC. (CN) 2024-07-18 US disclosed
EP-4310077-A1 BICYCLIC PHENOL COMPOUNDS AND USE THEREOF Medshine Discovery Inc. (CN) 2024-01-24 EP disclosed
US-11041027-B2 Polymerization process for producing ethylene based polymers DOW GLOBAL TECHNOLOGIES LLC (US) 2021-06-22 US disclosed
US-11041027-B2 Polymerization process for producing ethylene based polymers DOW GLOBAL TECHNOLOGIES LLC (US) 2021-06-22 US disclosed
CN-107787336-B Polymerization process for preparing ethylene-based polymers 陶氏环球技术有限责任公司 2021-05-28 CN disclosed
CN-107922538-B Polymerization process for the preparation of ethylene-based polymers 陶氏环球技术有限责任公司 2021-05-25 CN disclosed
EP-3736299-A1 A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS Dow Global Technologies Llc (US) 2020-11-11 EP disclosed
EP-3736299-A1 A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS Dow Global Technologies Llc (US) 2020-11-11 EP disclosed
EP-3317312-B1 A POLYMERIZATION PROCESS FOR PRODUCING ETHYLENE BASED POLYMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2020-06-10 EP disclosed
US-20050124692-A1 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents WYETH (US) 2005-06-09 US disclosed
WO-2005040146-A1 DIHYDROBENZOFURANYL ALKANAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM WYETH (US) 2005-05-06 WO disclosed
CN-1115334-C Pyridine derivative and medicine containing the same OTSUKA PHARMA CO LTD (JP) 2003-07-23 CN disclosed
US-6511995-B1 Inhibits collagen synthesis, which is useful for prophylaxis or treatment of fibrosis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2003-01-28 US disclosed
CN-1294581-A Pyridine derivative and pharmaceutical contg. same OTSUKA PHARMA CO LTD (JP) 2001-05-09 CN disclosed
EP-1066261-A1 PYRIDINE DERIVATIVE AND PHARMACEUTICAL CONTAINING THE SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-01-10 EP disclosed
WO-1999048871-A1 PYRIDINE DERIVATIVE AND PHARMACEUTICAL CONTAINING THE SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-09-30 WO disclosed
EP-0003664-B1 ALKANOLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-02-17 EP disclosed
US-4275058-A 1-(7-METHYLINDAN-4-YLOXY)-3-ISOPROPYLAMINOBUTAN-2-OL IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-06-23 US disclosed
EP-0003664-A1 Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1979-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124692-A1 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents HTR2C, HTR1A, HTR1B MAOA 68/4885MAOB 47/4885BCL2L1 2673/4885
US-20240239761-A1 BICYCLIC PHENOL COMPOUNDS AND USE THEREOF CYP3A43, CYP11B2, UGT2B7 MAOA 320/4885MAOB 135/4885BCL2L1 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.